Clinical trial
A Phase 2B Randomized Double Blind Placebo Controlled Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Direct Intramuscular Injection as Adjunct to Revascularization of Infrapopliteal Lesions in Subjects With Advanced Peripheral Artery Disease and Tissue Loss
NCT02544204 is registered in ClinicalTrials.gov with Juventas Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2B Randomized Double Blind Placebo Controlled Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Direct Intramuscular Injection as Adjunct to Revascularization of Infrapopliteal Lesions in Subjects With Advanced Peripheral Artery Disease and Tissue Loss
- Lead sponsor
- Juventas Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 30, 2015
- Completion date
- November 30, 2017
- Enrollment
- 120 (estimated)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.